Cargando…
Pilot study on developing a decision support tool for guiding re-administration of chemotherapeutic agent after a serious adverse drug reaction
BACKGROUND: Currently, there are no standard guidelines for recommending re-administration of a chemotherapeutic drug to a patient after a serious adverse drug reaction (ADR) incident. The decision on whether to rechallenge the patient is based on the experience of the clinician and is highly subjec...
Autores principales: | Loke, Pei Yi, Chew, Lita, Yap, Chun Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161037/ https://www.ncbi.nlm.nih.gov/pubmed/21794175 http://dx.doi.org/10.1186/1471-2407-11-319 |
Ejemplares similares
-
A serious nightmare: psychiatric and neurologic adverse reactions to mefloquine are serious adverse reactions
por: Nevin, Remington L.
Publicado: (2017) -
Meta-Analysis: Association Between Hypoglycemia and Serious Adverse Events in Older Patients Treated With Glucose-Lowering Agents
por: Mattishent, Katharina, et al.
Publicado: (2021) -
Intravenous Iron Therapy: Re-administration after Prior Adverse Reaction
por: Aung, Tim, et al.
Publicado: (2023) -
Predicting serious rare adverse reactions of novel chemicals
por: Poleksic, Aleksandar, et al.
Publicado: (2018) -
Evaluation of Chemotherapeutic Agents
por: Engstrom, W. W.
Publicado: (1949)